David A. Ramsay
2006
In 2006, David A. Ramsay earned a total compensation of $266.8K as Vice President and Chief Financial Officer at Halozyme Therapeutics, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $25,650 |
|---|---|
| Option Awards | $60,942 |
| Salary | $180,000 |
| Other | $162 |
| Total | $266,754 |
Ramsay received $180K in salary, accounting for 67% of the total pay in 2006.
Ramsay also received $25.7K in non-equity incentive plan, $60.9K in option awards and $162 in other compensation.
Rankings
In 2006, David A. Ramsay's compensation ranked 6,026th out of 7,022 executives tracked by ExecPay. In other words, Ramsay earned more than 14.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,026 out of 7,022 | 14th |
Division Manufacturing | 2,094 out of 2,413 | 13th |
Major group Chemicals And Allied Products | 584 out of 673 | 13th |
Industry group Drugs | 437 out of 518 | 16th |
Industry Biological Products, Except Diagnostic Substances | 98 out of 112 | 13th |
Source: SEC filing on April 2, 2009.
Ramsay's colleagues
We found five more compensation records of executives who worked with David A. Ramsay at Halozyme Therapeutics in 2006.
2006
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2006
Gregory Frost
Halozyme Therapeutics
Chief Scientific Officer
2006
Richard Yocum
Halozyme Therapeutics
Vice President — Clinical Development and Medical Affairs
2006
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2006
William Fallon
Halozyme Therapeutics